Global trends in the proportion of macrolide-resistant Mycobacterium Species: A systematic review and meta-analysis
PLOS One · 2025
DOI: 10.1371/journal.pone.0333521 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS One, 2025. Verfasst von Saeid Sadeghi Ghazi Chaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Biotechnology, School of Biology and Center of Excellence in Phylogeny of Living Organisms, College of Science, University of…. Hauptthemen laut MEDLINE: Macrolides, Drug Resistance, Bacterial, Anti-Bacterial Agents, Mycobacterium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Macrolide resistance in Mycobacterium species is an emerging global problem, complicating treating non-tuberculous mycobacteria (NTM) and Mycobacterium tuberculosis . Understanding global resistance patterns is essential to improve treatment strategies and reduce morbidity and mortality.
Objective
This study aimed to investigate macrolide resistance prevalence, distribution, and trends among Mycobacterium species in different world regions.
Methods
A comprehensive search of Scopus, PubMed, Web of Science, and EMBASE (2015–2023) assessed study quality using JBI guidelines. Resistance proportions were calculated with a random-effects model, and additional meta-regression and subgroup analyses explored variations and trends. Statistical analyses were conducted using R and the metafor package.
Results
Out of 5,718 records, 41 studies across 17 countries were included. Azithromycin resistance was reported in 17 reports (3 Studies), with 156 resistant isolates among 715 tested, yielding a pooled rate of 29.0% (95% CI: 19.5–40.7%). Clarithromycin resistance, assessed in 76 reports (40 Studies), included 1,071 resistant isolates among 3,923 tested, with a pooled rate of 30.5% (95% CI: 23.7–38.2%). Erythromycin resistance was reported in 17 reports (3 Studies), with 350 resistant isolates among 752 tested, giving a pooled rate of 50.3% (95% CI: 37.5–62.9%). Meta-regression revealed a significant upward trend in azithromycin resistance over time (r = 0.558, p = 0.005).
Conclusion
These findings underscore the need for targeted, region- and species-specific interventions to combat rising macrolide resistance in Mycobacterium species effectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbial Biotechnology, School of Biology and Center of Excellence in Phylogeny of Living Organisms, College of Science, University of Tehran, Tehran, Iran.
- Department of Biology, Faculty of Convergent Science and Technology, Sciences and Research Branch, Islamic. Azad University, Rasht, Iran.
- Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
- Department of Basic Sciences, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran.
- Department of Microbiology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
- School of Medicine, Hamadan University of Medical Science, Hamadan, Iran.
ORCID-Profile: Mohammad Sholeh
Zitieren
APA
Ghazi Chaki, S. S., Pirsoltan, S. B., Beig, M., Navidifar, T., Parvizi, E., Mofid, M., Golab, N., & Sholeh, M. (2025). Global trends in the proportion of macrolide-resistant Mycobacterium Species: A systematic review and meta-analysis. PLOS One. https://doi.org/10.1371/journal.pone.0333521
Vancouver
Ghazi Chaki SS, Pirsoltan SB, Beig M, Navidifar T, Parvizi E, Mofid M, et al. Global trends in the proportion of macrolide-resistant Mycobacterium Species: A systematic review and meta-analysis. PLOS One. 2025. doi:10.1371/journal.pone.0333521
BibTeX
@article{GhaziChaki2025,
author = {Ghazi Chaki, Saeid Sadeghi and Pirsoltan, Saeed Babaie and Beig, Masoumeh and Navidifar, Tahereh and Parvizi, Elnaz and Mofid, Maryam and Golab, Narges and Sholeh, Mohammad},
title = {Global trends in the proportion of macrolide-resistant Mycobacterium Species: A systematic review and meta-analysis},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0333521}
}
EUVIMED